JP2010083896A5 - - Google Patents

Download PDF

Info

Publication number
JP2010083896A5
JP2010083896A5 JP2009297192A JP2009297192A JP2010083896A5 JP 2010083896 A5 JP2010083896 A5 JP 2010083896A5 JP 2009297192 A JP2009297192 A JP 2009297192A JP 2009297192 A JP2009297192 A JP 2009297192A JP 2010083896 A5 JP2010083896 A5 JP 2010083896A5
Authority
JP
Japan
Prior art keywords
domain
protein
receptor antagonist
pharmaceutical composition
angiogenesis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009297192A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010083896A (ja
JP5221510B2 (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2010083896A publication Critical patent/JP2010083896A/ja
Publication of JP2010083896A5 publication Critical patent/JP2010083896A5/ja
Application granted granted Critical
Publication of JP5221510B2 publication Critical patent/JP5221510B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

JP2009297192A 2002-05-31 2009-12-28 ヒトプロラクチン拮抗剤−血管新生阻害剤融合蛋白質 Expired - Fee Related JP5221510B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US38412102P 2002-05-31 2002-05-31
US60/384,121 2002-05-31

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2002311540A Division JP4511108B2 (ja) 2002-05-31 2002-10-25 ヒトプロラクチン拮抗剤−血管新生阻害剤融合蛋白質

Publications (3)

Publication Number Publication Date
JP2010083896A JP2010083896A (ja) 2010-04-15
JP2010083896A5 true JP2010083896A5 (enExample) 2011-04-28
JP5221510B2 JP5221510B2 (ja) 2013-06-26

Family

ID=29711980

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2002311540A Expired - Fee Related JP4511108B2 (ja) 2002-05-31 2002-10-25 ヒトプロラクチン拮抗剤−血管新生阻害剤融合蛋白質
JP2009297192A Expired - Fee Related JP5221510B2 (ja) 2002-05-31 2009-12-28 ヒトプロラクチン拮抗剤−血管新生阻害剤融合蛋白質

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2002311540A Expired - Fee Related JP4511108B2 (ja) 2002-05-31 2002-10-25 ヒトプロラクチン拮抗剤−血管新生阻害剤融合蛋白質

Country Status (6)

Country Link
US (2) US7339027B2 (enExample)
EP (1) EP1513549A4 (enExample)
JP (2) JP4511108B2 (enExample)
AU (1) AU2003240974A1 (enExample)
CA (1) CA2487291A1 (enExample)
WO (1) WO2003102148A2 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003300904A1 (en) * 2002-12-13 2004-07-09 The Ohio State University Antagonists for human prolactin
US7666583B2 (en) 2004-02-19 2010-02-23 Yale University Identification of cancer protein biomarkers using proteomic techniques
AU2011213758B2 (en) * 2004-02-19 2012-11-15 Yale University Identification of cancer protein biomarkers using proteomic techniques
US7507716B2 (en) * 2005-07-06 2009-03-24 Board Of Regents, The University Of Texas System Method for treating pain with prolactin antagonists
CA2635588C (en) * 2005-12-30 2015-11-10 Dyax Corp. Metalloproteinase binding proteins
WO2009135056A2 (en) * 2008-04-30 2009-11-05 Monsanto Technology Llc Recombinant dna vectors for expression of human prolactin antagonists
WO2013034116A1 (zh) * 2011-09-09 2013-03-14 清华大学 对atp结合位点进行突变的血管内皮抑制素突变体
US10314909B2 (en) 2011-10-21 2019-06-11 Dyax Corp. Combination therapy comprising an MMP-14 binding protein

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2813428B2 (ja) * 1989-08-17 1998-10-22 三菱電機株式会社 電界効果トランジスタ及び該電界効果トランジスタを用いた液晶表示装置
US5315129A (en) * 1990-08-20 1994-05-24 University Of Southern California Organic optoelectronic devices and methods
TW222345B (en) * 1992-02-25 1994-04-11 Semicondustor Energy Res Co Ltd Semiconductor and its manufacturing method
FR2719480B1 (fr) * 1994-05-05 1996-07-26 Agronomique Inst Nat Rech Compositions pharmaceutiques destinées à prévenir et/ou traiter l'expression du comportement de couvaison chez les oiseaux et plus particulièrement chez la dinde et leurs procédés de préparation.
US6278127B1 (en) * 1994-12-09 2001-08-21 Agere Systems Guardian Corp. Article comprising an organic thin film transistor adapted for biasing to form a N-type or a P-type transistor
US5854205A (en) * 1995-10-23 1998-12-29 The Children's Medical Center Corporation Therapeutic antiangiogenic compositions and methods
WO1999016889A1 (en) * 1997-10-01 1999-04-08 G.D. Searle & Co. Fusion proteins comprising an angiostatin moiety and their use in anti-tumor treatment
EP1070122A4 (en) 1998-03-11 2004-11-10 Univ Texas INDUCTION OF APOPTIC OR CYTOTOXIC GENE EXPRESSION BY ADENOVIRUS-MEDIATED GENE TRANSFER
CN1308347C (zh) * 1999-04-28 2007-04-04 德克萨斯大学董事会 用于通过选择性抑制vegf来治疗癌症的组合物和方法
CA2404088A1 (en) * 2000-03-23 2001-09-27 Greenville Hospital System Bi-functional cancer treatment agents
JP2003000268A (ja) * 2000-08-25 2003-01-07 Pfizer Prod Inc 血管新生にかかわる疾患を診断および治療するための方法および組成物
JP4841751B2 (ja) * 2001-06-01 2011-12-21 株式会社半導体エネルギー研究所 有機半導体装置及びその作製方法
JP4136482B2 (ja) * 2002-06-20 2008-08-20 キヤノン株式会社 有機半導体素子、その製造方法および有機半導体装置
EP1684365A3 (en) * 2005-01-20 2008-08-13 Fuji Electric Holdings Co., Ltd. Transistor

Similar Documents

Publication Publication Date Title
JP2010083896A5 (enExample)
JP2012115277A5 (enExample)
JP2010534684A5 (enExample)
JP2013503110A5 (enExample)
JP2010519252A5 (enExample)
JP2014050390A5 (enExample)
JP2012082206A5 (enExample)
JP2017048194A5 (enExample)
JP2015533791A5 (enExample)
JP2012136541A5 (enExample)
MX2022011834A (es) Compuestos y metodos para el tratamiento de la enfermedad inflamatoria intestinal con manifestaciones extraintestinales.
JP2010065046A5 (enExample)
JP2013027391A5 (enExample)
JP2012529293A5 (enExample)
JP2012126742A5 (enExample)
JP2013507132A5 (enExample)
JP2011528896A5 (enExample)
JP2005516885A5 (enExample)
JP2016539089A5 (enExample)
JP2017113019A5 (enExample)
RU2015119517A (ru) Новый способ лечения инфаркта миокарда с применением фрагмента hmgb1
JP2013543499A5 (enExample)
JP2014529399A5 (enExample)
JP2015513318A5 (enExample)
JP2011521902A5 (enExample)